Program

The 11th Annual International Symposium on Liver & IBD Review Preliminary Program is available in the following formats:

Download/View PDF

Click here to register

Friday, January 19, 2018
6:30 pm – 10:30 pm Registration Open
6:30 pm – 10:30 pm President’s Welcome Dinner
   
Saturday, January 20, 2018
AM SESSIONS (7:30 am – 9:30 am)
7:00 am – 9:00 am Working Breakfast
7:30 am – 7:35 am Opening Remarks
Speaker: Dr. Imran Rasul

+/-

Imran Rasul, MD, FRCP(C)
Chair of the Endoscopy Unit
Credit Valley Hospital
President, OAG

Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.

7:35 am – 7:55 am Defining the Refractory IBD Patient
Speaker: Dr. Adam Weizman

+/-

Adam V. Weizman, MD, MSc, FRCPC
Division of Gastroenterology
Mount Sinai Hospital
Assistant Professor of Medicine
University of Toronto

Dr. Weizman is a gastroenterologist at Mount Sinai Hospital in Toronto, Ontario and an Assistant Professor of Medicine at the University of Toronto. He received his medical degree from the University of Manitoba and subsequently did a Residency in Internal Medicine and Fellowship in Gastroenterology at the University of Toronto. He completed the Advanced Fellowship in Inflammatory Bowel Diseases at Cedars-Sinai Medical Center in Los Angeles, California and a Master's degree (MSc) in Quality Improvement and Patient Safety from the Institute of Health Policy, Evaluation, and Management at the University of Toronto.  His research interests include healthcare quality and health outcomes, with a focus on inflammatory bowel disease (IBD). Dr. Weizman is the Head of Quality and Patient Safety for the division of gastroenterology at Mount Sinai Hospital and the University Health Network.

Presentation Overview:
This presentation will provide an overview on when to consider a patient with inflammatory bowel disease refractory to medical management.  Scenarios in which current therapy should be abandoned and/or referral for surgery should be considered will be used to define the refractory patient.  

7:55 am – 8:15 am The Refractory Fistulizing Patient
Speaker: Dr. Neeraj Narula

 

+/-

Neeraj Narula, MD, FRCPC
Assistant Professor, McMaster University

Dr. Neeraj Narula is an assistant professor of medicine at McMaster University and staff gastroenterologist in Hamilton Health Sciences. He completed the Present-Levison advanced IBD fellowship in Mount Sinai Medical Centre in New York, NY, in 2015. He trained to be a Chartered Accountant at the University of Waterloo and has worked at Ernst & Young and KPMG. He subsequently attended medical school at the University of Alberta. He completed internal medicine residency and gastroenterology fellowship training at McMaster University. He is completing a Masters of Public Health at Harvard TH Chan School of Public Health. His research interests are predominantly in clinical epidemiology, nutrition, and pharmaceutical trials in IBD.

Presentation Overview:
This presentation will review options for management of refractory perianal fistulas in Crohn's disease.

8:15 am – 8:35 am The Skin-Related EIMs
Speaker: Dr. Davindra Singh

+/-

Davindra Singh, BA, MD, CCFP (EM), FRCPC, DABD
Lead Dermatologist, AvantDerm
Assistant Professor, Faculty of Medicine, Laurentian University
Assistant Professor, Faculty of Medicine, Lakehead University
Adjunct Assistant Professor, Faculty of Medicine, Queen’s University

Dr. Davindra Singh has spent his career providing dedicated medical care to patients in under-serviced communities. He began practicing in Northern Ontario as a family doctor and emergency physician, and after switching gears to dermatology, is now the only visiting dermatologist in Timmins, Ontario.

In 2010, Dr. Singh opened AvantDerm, a full-service dermatology clinic located in Toronto. AvantDerm was created to address voids in care in innovative ways. The Rapid Access Clinic, the first of its kind in Toronto, drastically cuts waiting times in the GTA by allowing patients to walk-in with a referral. Dr. Singh also practices with a focus on ethnic skin care, having trained with experts from around the globe. This is particularly apt as Toronto is one of the most diverse cities in the world.

Dr. Singh is dedicated to the education of future medical practitioners, holding academic appointments at Queen’s University, Lakehead University and Laurentian University. He also places a great importance on giving back to the community and currently serves as the Chair of the Sikh Foundation of Canada.

8:35 am – 8:55 am Managing Patients Who Fail On Biologics
Speaker: Dr. Stephen Hanauer

+/-

Stephen B. Hanauer, MD, FACG
Professor of Medicine

Internationally recognized expert on the treatment of inflammatory bowel disease (IBD), former chair of the FDA Gastrointestinal Drugs Advisory Committee and advisor on the development of multiple leading IBD drugs

Dr. Hanauer is a board certified internist and gastroenterologist, and is the Clifford Joseph Barborka Professor of Medicine and Medical Director of the Digestive Health Center at Northwestern University’s Feinberg School of Medicine.  Dr. Hanauer is a Fellow and past President of the American College of Gastroenterology (ACG) and the former Chair of the American Gastroenterological Association’s Inflammation, Immunology, and IBD Section.  He is also a prior member of the Gastroenterology Specialty Board of the American Board of Internal Medicine and is a member and former-Chairman of the International Organization for Inflammatory Bowel Disease.  Among his many honors, Dr. Hanauer received the ACG’s Fiterman Foundation Joseph B. Kirsner Award in Gastroenterology and the Janssen Award for Clinical Excellence.  He has served as a member of the U.S. FDA Gastrointestinal Drugs Advisory Committee since 1987, he Chaired the Committee from 1998-2000, and he presently serves the Center for Drug Development and Research as a Special Consultant defining new guidelines for clinical evaluation of IBD patients. 

Dr. Hanauer has expertise in designing and leading clinical studies for IBD related therapies and has acted as a clinical investigator and/or advisor to pharmaceutical companies in the development of many of the leading IBD therapies, including:  Uceris®, Asacol HD®, Remicade®,Humira®, and Entyvio®. 

Dr. Hanauer has authored over 425 peer-reviewed journal articles and numerous books and book chapters, abstracts, monographs, and editorials.  He is the former-Editor-in-Chief of Nature Clinical Practice Gastroenterology & Hepatology and currently serves as Associate Editor (IBD) of Clinical Gastroenterology and Hepatology.  Dr. Hanauer is also a member of the editorial boards of other journals, most notably the American Journal of Gastroenterology and Inflammatory Bowel Diseases.

Dr. Hanauer received his medical degree from the University of Illinois Chicago, and he completed his residency in internal medicine and a fellowship in gastroenterology at the University of Chicago in 1982.  In 1999, he was named the Joseph B. Kirsner Chair in Medicine and was designated Chief of the Section of Gastroenterology, Hepatology and Nutrition at the University of Chicago.  In 2014, Dr. Hanauer was named the Medical Director of the Digestive Health Center at Northwestern Medicine and the Clifford Joseph Barborka Professor of Medicine in the Northwestern University’s Feinberg School of Medicine, where he continues to treat IBD patients and conducts research into new therapies.

8:55 am – 9:30 am Panel Discussion
Moderator: Dr. Sapna Makhija

+/-

Sapna Makhija, MD, FRCPC
Gastroenterologist, GI Health Centre

Dr. Makhija is a gastroenterologist and one of the cofounders of Burlington’s G.I. Health Centre. She completed her doctorate of medicine at the University of Saskatchewan and then completed both her internal medicine and gastroenterology training at the University of Calgary. She then decided to make the move to the University of Toronto for a fellowship in clinical nutrition and obesity.

Dr. Makhija has now dedicated most of her time to managing and working at G.I. Health Centre. When not practising clinical medicine, she devotes time to various committees relating to her field, travels the globe, and gets involved in community fundraisers.

 
9:30 am – 10:00 am Nutrition Break
  Lunch (On own)
 
PM SESSIONS (3:00 pm – 5:00 pm)
3:00 pm – 3:30 pm Nutrition Break
 
3:30 pm – 3:50 pm Refractory Autoimmune Liver Disease
Speaker: Dr. Aliya Gulamhusein

+/-

Aliya Gulamhusein , MD, MPH, FRCPC

Dr. Aliya Gulamhusein completed her undergraduate training at Queen's University and went on to complete her medical training at the University of Western Ontario. She did her residency in Internal Medicine followed by Gastroenterology at the University of Toronto and subsequently went on to pursue advanced hepatology training in cholestatic liver disease and liver transplant at the Mayo Clinic in Rochester, Minnesota. She completed her Masters in Public Health at the Bloomberg School of Public Health at John's Hopkins University before returning to the University of Toronto as an Assistant Professor and Clinician Investigator at the Toronto Centre for Liver Disease. She is the primary clinician for a thriving autoimmune liver diseases clinic which manages more than 1200 patients with PBC, PSC, and autoimmune hepatitis. As an investigator, her aims are to develop comprehensive databases aimed at characterizing the natural history, outcomes, and prognosis of patients with autoimmune liver disease and to link this data with biomarkers and genetic risk factors in the hopes of moving towards a personalized approach to care.

3:50 pm - 4:10 pm Refractory Viral Hepatitis
Speaker: Dr. Jordan Feld

+/-

Jordan Feld, MD, MPH
R. Phelan Chair in Translational Liver Research
Toronto Centre for Liver Disease
Toronto General Hospital, University Health Network
Sandra Rotman Centre for Global Health
Associate Professor of Medicine, University of Toronto

Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Currently, Dr. Feld is clinician-scientist based at the Toronto General Hospital, Toronto Centre for Liver Disease and the McLaughlin-Rotman Centre for Global Health.

Presentation Overview

  • Appreciate available options and strategies for retreatment of hepatitis C virus (HCV) infection after failure to respond to current first-line treatment options.
  • Understand the relevance of incomplete response and 'blips' during HBV therapy.
4:10 pm – 4:35 pm DEBATE: Refractory decompensated alcoholic liver disease: The indications for liver transplantation should be liberalized
Speaker: PRO - Dr. Anouar Teriaky
Speaker: CON - Dr. Anton Skaro

+/-

Anouar Teriaky, BSc (Hons), MD, FRCP(C)
Assistant Professor of Medicine
Western University
London Health Sciences Centre

Dr. Anouar Teriaky is an Assistant Professor of Medicine at Western University, a Clinician Teacher in the Department of Medicine, Division of Gastroenterology and Hepatology. He completed his Bachelor of Science with Honours in Biochemistry at the University of Ottawa followed by his MD at the University of Ottawa. He trained in Internal Medicine residency and Gastroenterology fellowship at Western University. Dr. Teriaky completed further training in Transplant and General Hepatology at the University of Chicago Medical Center. He is currently enrolled in the Master of Public Health program at Harvard University. His clinical interests include research in clinical outcomes in liver transplantation and hepatocellular carcinoma.

Presentation Overview:
Decompensated alcoholic liver disease can lead to great morbidity and mortality. Liver transplantation has been shown to drastically improve patient outcomes and survival. At present, patients are required to abstain from alcohol for 6 months before being eligible for assessment and listing for liver transplantation in Ontario. This requirement is not evidence based and has not been shown to decrease the risk of recidivism post liver transplant while improved patient outcomes has been demonstrated with early liver transplantation. The purpose of this presentation is to present the evidence supporting that liver transplantation timelines should be liberalized from the current 6 month abstinence period in patients with refractory decompensated alcoholic liver disease.


Anton I. Skaro, MD, FRCSC (C)
Associate Professor, Western University
Hepatobiliary, General Surgery, Liver Transplantation

London Health Sciences Centre - University Hospital
Surgical director of Liver Transplantation

Dr. Skaro joined the Faculty as an Associate Professor, Clinical Researcher Schulich School of Medicine & Dentistry at Western University on September 1, 2016 and is currently the Surgical Director of the Liver Transplant Program at London Health Sciences Center.

Dr. Skaro obtained his Doctor of Medicine degree from Western University in 1998. In June 2005 he completed surgical residency at Dalhousie University, while also obtaining his Doctor of Philosophy degree, and completing postdoctoral research training in transplant immunology. His fellowship in Abdominal Multi-organ Transplantation Surgery was completed at Northwestern University in Chicago in June 2007. He joined the Department of Surgery, Transplant Surgery at Northwestern University in June 2007 as an Assistant Professor, and was promoted to Associate Professor in 2014.

Dr Skaro has numerous publications and has been an active member of the transplant community with national visibility through service on committees of the American Society of Transplant Surgeons and the United Network for Organ Sharing. He has been actively involved in surgical education and research training/mentorship. Dr. Skaro’s research interests include clinical outcomes and health services research focused on risk prediction and econometrics, decision analytic modeling, and patient safety and the basic science of mechanisms involved in transplant rejection and the induction of transplantation tolerance.

4:35 pm – 5:00 pm Panel Discussion
Moderator: Dr. Imran Rasul

+/-

Imran Rasul, MD, FRCP(C)
Chair of the Endoscopy Unit
Credit Valley Hospital
President, OAG

Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.

 
6:00 pm – 10:00 pm Children's Program
6:30 pm – 11:30 pm President's African Safari Party
   
Sunday, January 21, 2018
7:15 am – 9:30 am Registration Open
7:30 am – 9:30 am Breakfast
 
8:00 am – 9:30 am

Case Presentations & Expert Panel Discussion:
IBD: Dr. Christopher Sheasgreen
Liver: Dr. Rowena Almeida

+/-

Chris Sheasgreen, MD, FRCPC
Clinical Fellow (IBD)
Mount Sinai Hospital, Toronto

Dr. Christopher Sheasgreen is currently an Advanced Clinical Fellow in Inflammatory Bowel Diseases through the University of Toronto at Mount Sinai Hospital. He completed his Internal Medicine (2014) and Gastroenterology (2016) training at McMaster University and his Medical Degree at the University of Ottawa in 2011.

Presentation Overview:
Two real-life clinical cases will be presented to the expert panel for an interactive discussion.


Dr. Rowena Almeida, MD, FRCPC
Clinical Fellow in Hepatology, University of Toronto,
Toronto Centre for Liver Disease, Toronto General Hospital

Dr. Rowena Almeida completed her Internal Medicine training at Queen's University, Kingston (2015), and recently graduated from the Gastroenterology training program at the University of Toronto (2017). She is currently pursuing an advanced clinical fellowship in Hepatology at the Toronto Centre for Liver Disease, at Toronto General Hospital as well as a Masters degree in System Leadership and Innovation with the Institute of Health Policy, Management and Evaluation at the University of Toronto.

 

Expert Panel:

  • Dr. Rowena Almeida
  • Dr. Jordan Feld
  • Dr. James Gregor
  • Dr. Aliya Gulamhusein
  • Dr. Neeraj Narula
  • Dr. Christopher Sheasgreen
  • Dr. Davindra Singh
  • Dr. Anton Skaro
  • Dr. Anouar Teriaky
  • Dr. Adam Weizman


Expert Panel Discussion
Moderator: Dr. James Gregor

+/-

James C. Gregor, MD, FRCP(C)
Victoria Hospital Site Chief,
London Health Sciences Centre
Associate Chair, Western University
Professor of Medicine,
Department of Medicine
London Health Sciences Centre - Victoria Hospital

Dr. James C. Gregor is a Professor of Medicine in the Departments of Medicine in the Schulich School of Medicine and Dentistry at Western University.

Dr. Gregor graduated from the University of Western Ontario in 1988, and specialized in Internal Medicine and Gastroenterology.   He did further training in Clinical Epidemiology and Health Economics at the University of Toronto.

Dr. Gregor joined the Medical Staff at The London Health Sciences Centre in 1995.  He served as Program Director for the Division of Gastroenterology from 1998 to 2009.  Currently he is the Site Chief for the Department of Medicine at the LHSC-Victoria Hospital, Associate Chair of Medicine at Western University.

Dr. Gregor is the President of the Ontario Association of Gastroenterology and is Chair and organizer of the annual Scholars’ Program for the Canadian Association of Gastroenterology.  He is past Chair of the Specialty Committee in Gastroenterology for the Royal College of Physicians & Surgeons of Canada.

His research interests include therapeutic endoscopy, inflammatory bowel disease, celiac disease and economic analysis and quality of life assessments in Gastroenterology.

 

 
9:30 am - 9:35 am Closing Remarks
Dr. David Morgan

 


© 2018 Ontario Association of Gastroenterology
^